Aducanumab (Mouse IGG2a) is a monoclonal antibody that selectively targets aggregated amyloid-beta (Abeta). The variable region of Aducanumab (Mouse IGG2a) is consistent with that of Aducanumab (HY-P9967), while the constant region is of Mouse IGG2a sequence. Aducanumab (Mouse IGG2a) has strong selectivity for Abeta fibrils with EC50s of >1 µM and 0.2 nM for monomeric Abeta1-40 and fibrillar Abeta1-42, respectively. Aducanumab (Mouse IGG2a) can be used for Alzheimers disease (AD) research[1].
Molecular Weight:
(147.019 kDa)
Purity:
99
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
